Back to Search
Start Over
Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma
- Source :
- BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018), BMC Cancer
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- Background The key-stone-pathogen, Porphyromonas gingivalis associates not only with periodontal diseases but with a variety of other chronic diseases such as cancer. We previously reported an association between the presence of Porphyromonas gingivalis in esophageal squamous cell carcinoma (ESCC) and its progression. We now report the diagnostic and prognostic potential of serum immunoglobulin G and A antibodies (IgG/A) against Porphyromonas gingivalis for ESCC. Methods An enzyme-linked immunosorbent assay (ELISA) was used to determine the serum levels of Porphyromonas gingivalis IgG and IgA in 96 cases with ESCC, 50 cases with esophagitis and 80 healthy controls. Results The median serum levels of IgG and IgA for P. gingivalis were significantly higher in ESCC patients than non-ESCC controls. P. gingivalis IgG and IgA in serum demonstrated sensitivities/specificities of 29.17%/96.90% and 52.10%/70.81%, respectively, and combination of IgG and IgA produced a sensitivity/specificity of 68.75%/68.46%. The diagnostic performance of serum P. gingivalis IgA for early ESCC was superior to that of IgG (54.54% vs. 20.45%). Furthermore, high serum levels of P. gingivalis IgG or IgA were associated with worse prognosis of ESCC patients, in particular for patients with stage 0-IIor negative lymphnode metastasis, and ESCC patients with high levels of both IgG and IgA had the worst prognosis. Multivariate analysis revealed that lymph node status, IgG and IgA were independent prognostic factors. Conclusions The IgG and IgA for P. gingivalis are potential serum biomarkers for ESCC and combination of IgG and IgA improves the diagnostic and prognostic performance. Furthermore, serum P. gingivalis IgG and IgA can detect early stage ESCC. Electronic supplementary material The online version of this article (10.1186/s12885-017-3905-1) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
0301 basic medicine
Immunoglobulin A
Cancer Research
Esophageal Neoplasms
Gastroenterology
Immunoglobulin G
Metastasis
0302 clinical medicine
Diagnosis
Bacteroidaceae Infections
Lymph node
biology
Middle Aged
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Antibodies, Bacterial
Survival Rate
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Carcinoma, Squamous Cell
Immunoglobulin G/A
Female
Antibody
Porphyromonas gingivalis
Research Article
medicine.medical_specialty
Enzyme-Linked Immunosorbent Assay
lcsh:RC254-282
03 medical and health sciences
Esophageal squamous cell carcinoma
Internal medicine
Preoperative Care
Biomarkers, Tumor
Genetics
medicine
Humans
neoplasms
Survival rate
Antigens, Bacterial
business.industry
Cancer
medicine.disease
biology.organism_classification
digestive system diseases
030104 developmental biology
biology.protein
business
Follow-Up Studies
Subjects
Details
- ISSN :
- 14712407
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- BMC Cancer
- Accession number :
- edsair.doi.dedup.....7956cb79591a936530c8e31944763e72
- Full Text :
- https://doi.org/10.1186/s12885-017-3905-1